Enanta Pharmaceuticals
Patents, Design & Utilities

Last updated:

List of all Enanta Pharmaceuticals patents 112 in total

Status Patent
Grant
Utility: Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 29 Oct 2019
Application
Utility: HEPATITIS B ANTIVIRAL AGENTS External link
Filling date: 6 Sep 2025 Issue date: 24 Oct 2019
Grant
Utility: Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 22 Oct 2019
Grant
Utility: Isoxazole analogs as FXR agonists and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 22 Oct 2019
Application
Utility: HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 17 Oct 2019
Grant
Utility: Hepatitis B antiviral agents External link
Filling date: 6 Sep 2025 Issue date: 15 Oct 2019
Application
Utility: PROCESSES FOR THE PREPARATION OF BENZODIAZEPINE DERIVATIVES External link
Filling date: 6 Sep 2025 Issue date: 10 Oct 2019
Grant
Utility: Hepatitis B antiviral agents External link
Filling date: 6 Sep 2025 Issue date: 1 Oct 2019
Grant
Utility: Heteroaryldiazepine derivatives as RSV inhibitors External link
Filling date: 6 Sep 2025 Issue date: 3 Sep 2019
Application
Utility: MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 29 Aug 2019
Application
Utility: ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 15 Aug 2019
Grant
Utility: Deuterated bile acid derivatives as FXR/TGR5 agonists and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 30 Jul 2019

Showing 100 to 112 of 112 patents.